Clinical Trials in Rionegro, Antioquia

Find clinical trials in Rionegro, Antioquia. Discover local research opportunities and treatment options in your area.

8 Active Trials Found in Rionegro

Showing 8 trials on this page

Page 1 of 1

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

NCT ID: NCT06252649

This clinical trial is studying a new treatment approach for patients with metastatic colorectal cancer that has a specific genetic change known as the KRAS p.G12C mutation. Researchers want to see...

Recruiting

Phase: PHASE3 Conditions: Metastatic Colorectal Cancer

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

NCT ID: NCT06926868

The IZABRIGHT-Breast01 clinical trial is studying a new treatment option called Izalontamab Brengitecan (or iza-bren) for patients with a type of breast cancer known as triple-negative breast cance...

Recruiting

Phase: PHASE2 Conditions: Breast Neoplasms

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT ID: NCT06052059

This clinical trial is studying a new medication called tulisokibart (MK-7240) to see if it is effective and safe for people with moderately to severely active ulcerative colitis, a condition that ...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

NCT ID: NCT06875310

The KRYSTAL-4 trial is studying a new treatment approach for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has a mutation known as KRAS G12C. This tria...

Recruiting

Phase: PHASE3 Conditions: Carcinoma, Non-Small-Cell Lung

Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine

NCT ID: NCT03836040

This clinical trial is studying a medication called erenumab to see if it can help prevent migraines in children and teenagers aged 6 to under 18 years who have episodic migraines. The goal is to f...

Recruiting

Phase: PHASE3 Conditions: Migraine

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

NCT ID: NCT04375800

This clinical trial is studying a medication called doravirine (DOR) to see how well it works and how safe it is for children with HIV-1, ages 4 weeks to under 12 years, who weigh less than 45 kg. ...

Recruiting

Phase: PHASE2 Conditions: Human Immunodeficiency Virus (HIV) Infection

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

NCT ID: NCT05587712

This clinical trial is studying a medication called sotatercept to see how safe it is and how well it works in children aged 1 to 17 years who have Pulmonary Arterial Hypertension (PAH). PAH is a c...

Recruiting

Phase: PHASE2 Conditions: Pulmonary Arterial Hypertension

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

NCT ID: NCT05714085

This clinical trial is studying a medication called vericiguat to see how well it works in children and young adults with heart failure due to a specific type of heart dysfunction known as left ven...

Recruiting

Phase: PHASE2 Conditions: Heart Failure, Left Ventricular Systolic Dysfunction

Search All Trials Browse All Locations